Unbiased Analysis of Today's Healthcare Issues
In health care, decisions are always made with imperfect information. How ambiguity affects stakeholder decisionmaking and in particular how ambiguity interacts with risk preferences to affect decisions is unknown. A paper by Attema, Bleichrodt and L’Haridon (2018) aims to answer this question using a general ambiguity model. They find that: For health gains, ambiguity preferences…
Uber ambulences? The impact of the sunshine act. Aging is not as bad as we think. Nurse complaint from 1898 that rings true today. Pre-existing conditions fact check.
In 2010, Premera Blue Cross (Premera), a large nonprofit health plan in the Pacific Northwest implemented a value-based formulary design for its beneficiaries. In essence, enrollees could purchase high-value treatments for low copayments and low-value treatments for higher copayments. Can we use this change from more standard to value-base formulary designs to estimate the price elasticity…
An interesting study from Garthwaite 2012 examines the removal of Cox-2 inhibitors. Rather than measuring the direct effect of Cox-2 inhibitors on quality of life or health status, Garthwaite examines how this removal affected labor market outcomes. Despite dramatic improvements in medical technology, little attention has been paid to the role of these innovations in…
The Nobel Prize in Economics (formally the Sveriges Riksbank Prize in Economic Sciences in Memory of Alfred Nobel) was awarded to William Nordhaus and Paul Romer. For Romer, the Nobel Prize committee cited his work on endogenous growth theory, that models “how economic decisions and market conditions determine the creation of new technologies. Paul Romer solved…
Many of my readers will know what adverse selection is, but to reiterate, adverse selection occurs in health insurance markets when sicker patients decide to choose specific types of plans. If a health insurer believes they will have a representative sample of enrollees but instead they have a disproportionate share of sick individuals, they will…
This year’s MacArthur “Genius” Fellows were announced today. While there is a great diversity of amazing individuals receiving the grants, I will focus on those related to the health care space: Amy Finkelstein: health economist, at MIT, who is formulating robust experimental designs that provide data-driven guidance for innovations in health care theory, policy, and delivery…
Drug prices under Trump. Competition in HCV treatment. Shale gas drilling and infant health. Winning worse than losing. Manski responds.
This is the topic of a recent publication with co-authors Kata Bognar, Katie Everson, Michelle Brauer, Darius Lakdawalla and Felicia Forma. The full title is Does knowledge of patient non-compliance change prescribing behavior in the real world? A claims-based analysis of patients with serious mental illness. The abstract is below, but do read the whole thing…
The winners are James P. Allison and Tasuku Honjo for research to treat cancer using the body’s own immune system. The Nobel Prize officially was “for their discovery of cancer therapy by inhibition of negative immune regulation.” The Wall Street Journal reports: The work of Drs. Allison and Honjo formed the backbone of new generations…